XtalPi and Pfizer Expand Partnership to Advance AI Drug Discovery

To improve its AI-driven drug discovery and materials science simulations, XtalPi, an AI-powered medication R&D business, has extended its strategic partnership with Pfizer

Biocon Biologics Marks Major Milestone in Advancing Diabetes Care

Biocon Biologics reported that Biocon Sdn. Bhd., its Malaysian subsidiary, has exceeded the milestone of providing the Malaysian Ministry of Health (MoH) with 100 million recombinant human insulin (rh-insulin) cartridges.

FSSAI Orders Full Inspection of Packaged Water Units in Maharashtra

In a major decision to enhance the food safety standards, the Food Safety and Standards Authority of India (FSSAI) has ordered a "100 per cent inspection" of all packaged drinking water units in Maharashtra.

CDSCO Shifts WHO-GMP and COPP Applications to ONDLS Portal

As part of a major step to digitisation of India’s pharmaceutical regulatory processes, the Central Drugs Standard Control Organisation (CDSCO) announced that effective 15 July 2025, all applications for World Health Organisation Good Manufacturin...

India Leads the World in Vaccine R&D and Health Tech Says Jitendra

India is presently a global healthcare innovation leader, a drug manufacturing hub, and a vaccine maker, Union Minister of State for Science & Technology Jitendra Singh stated at the Times Now Doctors Day Conclave 2025

PharmaTech 2025: India's Premier Pharma & LabTech Event

PharmatechnologyIndex.com Private Ltd, together with the Drug Marketing & Manufacturing Association (DMMA) will organize the PharmaTech Expo & LabTech Expo 2025 and the 20th edition at Helipad Exhibition Centre, Gandhinagar, Gujarat from August...

Alembic Gets USFDA Nod for Cancer Drug in Single-Dose Vials

Alembic Pharmaceuticals Limited has received final approval of the U.S. Food and Drug Administration (USFDA) on its generic Doxorubicin Hydrochloride Liposome Injection (10 mg/5 mL, 20 mg/10 mL and 50 mg/25 mL) in single dose ampoule...

DCC Approves Proposal to Include GDP in Drugs Regulation

Drugs Consultative Committee (DCC) has also sanctioned a proposal to amend the Drugs Rules, 1945, with the inclusion of Good Distribution Practices (GDP) guidelines as a standalone schedule.

Indian pharma speeds up access to global therapies while targeting treatment gaps

India's pharmaceutical industry is charging ahead with a fast pace towards quicker access to internationally cleared drugs, along with filling crucial gaps in the treatment requirements of the country's health care system.

Eli Lilly Launches Mounjaro Pen in India to Tackle Diabetes, Obesity

Eli Lilly has announced that its diabetes and obesity medicine, Mounjaro, will be available in a prefilled pen format in India, which can increase competition in the fast-growing chronic care space. The company received approval from the Central...

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.